Follow

Submissions from 2022

Link

Real-world evidence on atopic dermatitis: Baseline characteristics and predictors of treatment choice in the TARGET cohort, Katrina Abuabara, Lawrence F. Eichenfield, Robert Bissonnette, Jonathan I. Silverberg, Jerry Bagel, Emma Guttman-Yassky, Diamant Thaci, Eric L. Simpson, John E. Harris, James Krueger, Daniela E. Myers, Amy Gamelli, Marina Milutinovic, Anne Parneix, Julie M. Crawford, Breda Munoz, and Amy S. Paller

Link

Benign Familial Pemphigus, Nagasai C. Adusumilli and Adam J. Friedman

Link

Shoe Allergens: A Retrospective Analysis of Cross-sectional Data From the North American Contact Dermatitis Group, 2005-2018, Amber Reck Atwater, Raina Bembry, Cynthia L. Green, Joel G. DeKoven, Erin M. Warshaw, Donald V. Belsito, Howard I. Maibach, Jonathan I. Silverberg, James S. Taylor, Margo J. Reeder, Kathryn A. Zug, Joseph F. Fowler, Melanie D. Pratt, Denis Sasseville, and Vincent A. DeLeo

Link

Bleach baths for atopic dermatitis: A systematic review and meta-analysis including unpublished data, Bayesian interpretation, and GRADE, Layla Bakaa, Jeffrey M. Pernica, Rachel J. Couban, Kelly Jo Tackett, Craig N. Burkhart, Liz Leins, Joanne Smart, Maria Teresa Garcia-Romero, Itzel Guadalupe Elizalde-Jiménez, Michael Herd, Rachel Netahe Asiniwasis, Mark Boguniewicz, Anna De Benedetto, Lina Chen, Kathy Ellison, Winfred Frazier, Matthew Greenhawt, Joey Huynh, Jennifer LeBovidge, Mary Laura Lind, Peter Lio, Monica O'Brien, Peck Y. Ong, Jonathan I. Silverberg, Jonathan M. Spergel, Julie Wang, Wendy Smith Begolka, Lynda Schneider, and Derek K. Chu

Link

The Family Impact of Atopic Dermatitis in the Pediatric Population: Results from an International Cross-sectional Study, Sebastien Barbarot, Jonathan I. Silverberg, Abhijit Gadkari, Eric L. Simpson, Stephan Weidinger, Paola Mina-Osorio, Ana B. Rossi, Lysel Brignoli, Tarek Mnif, Isabelle Guillemin, Miriam C. Fenton, Marine Pellan, Puneet Mahajan, Dimittri Delevry, Ashish Bansal, and Laurent Eckert

Link

Comparing abrocitinib and dupilumab in the treatment of atopic dermatitis: a plain language summary, Thomas Bieber, Eric L. Simpson, Jonathan I. Silverberg, Diamant Thaçi, Carle Paul, Andrew E. Pink, Yoko Kataoka, Chia-Yu Chu, Marco DiBonaventura, Ricardo Rojo, Jeremias Antinew, Ileana Ionita, Rodney Sinclair, Seth Forman, Jacek Zdybski, Pinaki Biswas, Bimal Malhotra, Fan Zhang, and Hernan Valdez

Link

Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3, Andrew Blauvelt, Melinda Gooderham, Neal Bhatia, Richard G. Langley, Shannon Schneider, John Zoidis, Azra Kurbasic, April Armstrong, and Jonathan I. Silverberg

Link

Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitis, Andrew Blauvelt, Leon Kircik, Kim A. Papp, Eric L. Simpson, Jonathan I. Silverberg, Brian S. Kim, Shawn G. Kwatra, Michael E. Kuligowski, May E. Venturanza, Shaoceng Wei, and Jacek C. Szepietowski

Link

Itch-Free State in Patients With Atopic Dermatitis Treated With Ruxolitinib Cream: Pooled Analysis From Two Randomized Phase 3 Studies, Andrew Blauvelt, Jacek C. Szepietowski, Kim Papp, Eric L. Simpson, Jonathan I. Silverberg, Brian S. Kim, Shawn G. Kwatra, Michael E. Kuligowski, May E. Venturanza, Shaoceng Wei, and Leon Kircik

Link

Impact of Ruxolitinib Cream on Work Productivity and Activity Impairment and Associated Indirect Costs in Patients with Atopic Dermatitis: Pooled Results From Two Phase III Studies, Lisa Bloudek, Lawrence F. Eichenfield, Jonathan I. Silverberg, Vijay N. Joish, Jennifer H. Lofland, Kang Sun, Matthias Augustin, Kristen Migliaccio-Walle, and Sean D. Sullivan

Link

Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity, Otavio Cabral-Marques, Gilad Halpert, Lena F. Schimke, Yuri Ostrinski, Aristo Vojdani, Gabriela Crispim Baiocchi, Paula Paccielli Freire, Igor Salerno Filgueiras, Israel Zyskind, Miriam T. Lattin, Florian Tran, Stefan Schreiber, Alexandre H. Marques, Desirée Rodrigues Plaça, Dennyson Leandro Fonseca, Jens Y. Humrich, Antje Müller, Lasse M. Giil, Hanna Graßhoff, Anja Schumann, Alexander Hackel, Juliane Junker, Carlotta Meyer, Hans D. Ochs, Yael Bublil Lavi, Carmen Scheibenbogen, Ralf Dechend, Igor Jurisica, Kai Schulze-Forster, Jonathan I. Silverberg, Howard Amital, and Jason Zimmerman

Link

Longitudinal course and predictors of depressive symptoms in atopic dermatitis, Sheena Chatrath, Donald Lei, Muhammad Yousaf, Rajeev Chavda, Sylvie Gabriel, and Jonathan I. Silverberg

Link

Atopic Dermatitis Is Associated With Lower Patient Satisfaction in US Adults, Brian T. Cheng and Jonathan I. Silverberg

Link

Financial burden and impact of atopic dermatitis out-of-pocket healthcare expenses among black individuals in the United States, Raj Chovatiya, Wendy Smith Begolka, Isabelle J. Thibau, and Jonathan I. Silverberg

Link

Impact and Associations of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States, Raj Chovatiya, Wendy Smith Begolka, Isabelle J. Thibau, and Jonathan I. Silverberg

Link

DESCRIBE-AD: A novel classification framework for atopic dermatitis, Raj Chovatiya and Jonathan I. Silverberg

Link

Evaluating the longitudinal course of atopic dermatitis: A review of the literature, Raj Chovatiya and Jonathan I. Silverberg

Link

Evaluating the Longitudinal Course of Atopic Dermatitis: Implications for Clinical Practice, Raj Chovatiya and Jonathan I. Silverberg

Link

Iatrogenic Burden of Atopic Dermatitis, Raj Chovatiya and Jonathan I. Silverberg

Link

Unbiased discovery of autoantibodies associated with severe COVID-19 via genome-scale self-assembled DNA-barcoded protein libraries, Joel J. Credle, Jonathan Gunn, Puwanat Sangkhapreecha, Daniel R. Monaco, Xuwen Alice Zheng, Hung-Ji Tsai, Azaan Wilbon, William R. Morgenlander, Andre Rastegar, Yi Dong, Sahana Jayaraman, Lorenzo Tosi, Biju Parekkadan, Alan N. Baer, Mario Roederer, Evan M. Bloch, Aaron A. Tobian, Israel Zyskind, Jonathan I. Silverberg, Avi Z. Rosenberg, Andrea L. Cox, Tom Lloyd, Andrew L. Mammen, and H Benjamin Larman

Link

AAD Guidelines: awareness of comorbidities associated with atopic dermatitis in adults, Dawn M. Davis, Aaron M. Drucker, Ali Alikhan, Lionel Bercovitch, David E. Cohen, Jennifer M. Darr, Lawrence F. Eichenfield, Lindsy Frazer-Green, Amy S. Paller, Jonathan I. Silverberg, Anne Marie Singh, and Robert Sidbury

Link

Sleep impairment in patients with chronic inflammatory skin diseases: A review of mechanisms and management, Grace Y. Duan and Jonathan I. Silverberg

Link

An intertriginous eruption in an infant, Adaora Ewulu, Michael A. Cardis, and Kaiane A. Habeshian

Link

1,550 nm Erbium-Doped and 1,927 nm Thulium Nonablative Fractional Laser System: Best Practices and Treatment Setting Recommendations, Paul M. Friedman, Jeffrey S. Dover, Anne Chapas, Zakia Rahman, Edward V. Ross, Suzanne L. Kilmer, Wendy E. Roberts, Pooja Sodha, Julie B. Stimmel, Mary Beth Moncrief, and Jill S. Waibel

Link

Clinical features and eosinophilia in pityriasis rubra pilaris: A multicenter cohort, Shilpa Ghatnekar, Nidhi Shah, Michelle S. Min, Daniel R. Mazori, Avery H. LaChance, Ruth Ann Vleugels, and Vinod E. Nambudiri

Link

Durability of Response to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis After Treatment Discontinuation in a Phase 2b Trial, Melinda J. Gooderham, Giampiero Girolomoni, Julian O. Moore, Jonathan I. Silverberg, Robert Bissonnette, Seth Forman, Elena Peeva, Pinaki Biswas, Hernan Valdez, and Gary Chan

Link

Durability of Response to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis After Treatment Discontinuation in a Phase 2b Trial, Melinda J. Gooderham, Giampiero Girolomoni, Julian O. Moore, Jonathan I. Silverberg, Robert Bissonnette, Seth Forman, Elena Peeva, Pinaki Biswas, Hernan Valdez, and Gary Chan

Enhancing Topical Pharmacotherapy for Acne and Rosacea: Vehicle Choices and Outcomes, Lawrence J. Green, Edward Lain, Thomas Prunty, and Robert Rhoades

Link

Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma, Neil D. Gross, David M. Miller, Nikhil I. Khushalani, Vasu Divi, Emily S. Ruiz, Evan J. Lipson, Friedegund Meier, Yungpo B. Su, Paul L. Swiecicki, Jennifer Atlas, Jessica L. Geiger, Axel Hauschild, Jennifer H. Choe, Brett G. Hughes, Dirk Schadendorf, Vishal A. Patel, Jade Homsi, Janis M. Taube, Annette M. Lim, Renata Ferrarotto, Howard L. Kaufman, Frank Seebach, Israel Lowy, Suk-Young Yoo, Melissa Mathias, Keilah Fenech, Hyunsil Han, Matthew G. Fury, and Danny Rischin

Link

Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma, Neil D. Gross, David M. Miller, Nikhil I. Khushalani, Vasu Divi, Emily S. Ruiz, Evan J. Lipson, Friedegund Meier, Yungpo B. Su, Paul L. Swiecicki, Jennifer Atlas, Jessica L. Geiger, Axel Hauschild, Jennifer H. Choe, Brett G. Hughes, Dirk Schadendorf, Vishal A. Patel, Jade Homsi, Janis M. Taube, Annette M. Lim, Renata Ferrarotto, Howard L. Kaufman, Frank Seebach, Israel Lowy, Suk-Young Yoo, Melissa Mathias, Keilah Fenech, Hyunsil Han, Matthew G. Fury, and Danny Rischin

Link

Clinical Efficacy of a Digital Intervention for Patients with Atopic Dermatitis: a Prospective Single-Center Study, Sigrídur Lára Gudmundsdóttir, Tommaso Ballarini, María L. Ámundadóttir, Judit Mészáros, Jenna H. Eysteinsdóttir, Ragna H. Thorleifsdóttir, Sigrídur K. Hrafnkelsdóttir, Heida B. Bragadóttir, Saemundur Oddsson, and Jonathan I. Silverberg

Link

Clinical Efficacy of a Digital Intervention for Patients with Atopic Dermatitis: a Prospective Single-Center Study, Sigrídur Lára Gudmundsdóttir, Tommaso Ballarini, María L. Ámundadóttir, Judit Mészáros, Jenna H. Eysteinsdóttir, Ragna H. Thorleifsdóttir, Sigrídur K. Hrafnkelsdóttir, Heida B. Bragadóttir, Saemundur Oddsson, and Jonathan I. Silverberg

Link

Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies, Emma Guttman-Yassky, Jacob P. Thyssen, Jonathan I. Silverberg, Kim A. Papp, Amy S. Paller, Stephan Weidinger, H Chih-Ho Hong, Barbara Hendrickson, Deanne Dilley, Allan R. Tenorio, Barry Ladizinski, Alvina D. Chu, John Liu, and Alan D. Irvine

Link

Psychological Interventions Are More Effective Than Educational Interventions at Improving Atopic Dermatitis Severity: A Systematic Review, Tammy Hua, Lori S. Kim, Muhammad Yousaf, Eran C. Gwillim, Yik W. Yew, Brad Lee, Kevin Hua, Taylor Erickson, Brian Cheng, Kevin Patel, and Jonathan Ian Silverberg

Link

Assessment of the validity of international classification of disease tenth revision codes for atopic dermatitis, Sneha Iyer, Nisha Patel, Eric Sanfilippo, Robert P. Dellavalle, and Jonathan I. Silverberg

Link

Tropical parasitic itch in returned travellers and immigrants from endemic areas, T Ju, A Vander Does, G Ingrasci, S A. Norton, and G Yosipovitch

Link

Differences in Psychometric Properties of Clinician- and Patient-Reported Outcome Measures for Atopic Dermatitis by Race and Skin Tone: A Systematic Review, Trisha Kaundinya, Uros Rakita, Armaan Guraya, Donna Maria Abboud, Emily Croce, Jacob P. Thyssen, Andrew Alexis, and Jonathan I. Silverberg

Link

Efficacy and tolerability of three topical acne treatments by body mass index: post hoc analysis including overweight and obese patients, Jonette Keri, Fran E. Cook-Bolden, Lawrence Green, Leon H. Kircik, Hilary Baldwin, William Philip Werschler, Eric Guenin, Radhakrishnan Pillai, and Varsha Bhatt

Link

Feeling the burn: Sunburn recall in staphylococcal scalded skin syndrome, Rayva Khanna, Emily L. Guo, and Anna Yasmine Kirkorian

Link

Dermal sensitization, safety, tolerability, and patient preference of tazarotene 0.045% lotion from five clinical trials, Leon H. Kircik, Lawrence Green, Eric Guenin, Waleed Khalid, and Binu Alexander

Link

Combination 1550 nm non-ablative fractional resurfacing and laser hair removal for treatment of Becker's nevi in skin types III-VI, Shelby L. Kubicki, Emily L. Guo, Pooja Sodha, Heather Richmond, and Paul M. Friedman

Link

Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials, Mark G. Lebwohl, Leon H. Kircik, Angela Y. Moore, Linda Stein Gold, Zoe D. Draelos, Melinda J. Gooderham, Kim A. Papp, Jerry Bagel, Neal Bhatia, James Q. Del Rosso, Laura K. Ferris, Lawrence J. Green, Adelaide A. Hebert, Terry Jones, Steven E. Kempers, David M. Pariser, Paul S. Yamauchi, Matthew Zirwas, Lorne Albrecht, Alim R. Devani, Mark Lomaga, Amy Feng, Scott Snyder, Patrick Burnett, Robert C. Higham, and David R. Berk

Link

Posttreatment maintenance of therapeutic effect with fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion for moderate-to-severe plaque psoriasis, Mark G. Lebwohl, Linda Stein Gold, James Q. Del Rosso, Lawrence Green, and Abby Jacobson

Link

Subgroup Analysis of Crisaborole for Mild-to-Moderate Atopic Dermatitis in Children Aged 2 to < 18 Years, Thomas A. Luger, Adelaide A. Hebert, Andrea L. Zaenglein, Jonathan I. Silverberg, Huaming Tan, William C. Ports, and Michael A. Zielinski

Link

Longitudinal Course of Sleep Disturbance and Relationship With Itch in Adult Atopic Dermatitis in Clinical Practice, Jaya Manjunath, Donald Lei, Adnan Ahmed, Marissa Ayasse, Rajeev Chavda, Sylvie Gabriel, and Jonathan Ian Silverberg

Link

Association of obesity in early childhood with atopic dermatitis in late childhood and adolescence, Jaya Manjunath and Jonathan I. Silverberg

Link

A dialysis patient with subungual hyperkeratosis and ulceration of the fingertips, Sarah H. Millan, Karl M. Saardi, Ardeshir Edward Nadimi, and Scott A. Norton

Link

Racial disparities in dermatology, Shanthi Narla, Candrice R. Heath, Andrew Alexis, and Jonathan I. Silverberg

Link

The suitability of treating atopic dermatitis with Janus kinase inhibitors, Shanthi Narla and Jonathan I. Silverberg

Link

Practices and perspectives on medical cannabis and cannabinoids: A survey of the National Psoriasis Foundation Medical Advisory Board, Dillon Nussbaum, Sapana Desai, Adrianna Gonzalez-Lopez, Jason E. Hawkes, George Gondo, and Adam Friedman

Link

Reduction in new pityriasis rosea diagnoses during the COVID-19 pandemic: Evidence in support of a viral etiology, Dillon Nussbaum, Chapman Wei, Haig Pakhchanian, Rahul Raiker, Ivan Z. Liu, and Adam Friedman

Link

Reply to "Pityriasis rosea during COVID-19 and its pathogenesis", Dillon Nussbaum, Chapman Wei, Haig Pakhchanian, Rahul Raiker, Ivan Z. Liu, and Adam Friedman

Link

Dietary Elimination for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis, Paul Oykhman, Jared Dookie, Husam Al-Rammahy, Anna de Benedetto, Rachel N. Asiniwasis, Jennifer LeBovidge, Julie Wang, Peck Y. Ong, Peter Lio, Alvin Gutierrez, Korey Capozza, Stephen A. Martin, Winfred Frazier, Kathryn Wheeler, Mark Boguniewicz, Jonathan M. Spergel, Matthew Greenhawt, Jonathan I. Silverberg, Lynda Schneider, and Derek K. Chu

Link

The utility of laboratory testing for pediatric patients undergoing isotretinoin treatment, Varsha Parthasarathy, Nidhi Shah, and Anna Yasmine Kirkorian

PDF

Cutaneous squamous cell carcinoma staging may influence management in users: A survey study., Vishal A. Patel, Catherine McCullum, Andrew D. Sparks, Chrysalyne D Schmults, Sarah T Arron, and Anokhi Jambusaria-Pahlajani

Link

A pooled analysis of randomized, controlled, phase 3 trials investigating the efficacy and safety of a novel, fixed dose calcipotriene and betamethasone dipropionate cream for the topical treatment of plaque psoriasis, A Pinter, L J. Green, J Selmer, M Praestegaard, L S. Gold, and M Augustin

Link

Psychometric validation and responder definition of the sleep disturbance numerical rating scale in moderate-to-severe atopic dermatitis, J Puelles, F Fofana, D Rodriguez, J I. Silverberg, A Wollenberg, C Dias Barbosa, M Vernon, R Chavda, S Gabriel, and C Piketty

Link

Association of atopic dermatitis severity with menstrual worsening of disease in women: a cross-sectional study., U Rakita, T Kaundinya, and J I. Silverberg

Link

Associations between onychomycosis and COVID-19 clinical outcomes: a retrospective cohort study from a US metropolitan center, Uros Rakita, Trisha Kaundinya, Armaan Guraya, Kamaria Nelson, Brittany Maner, Jaya Manjunath, Gabrielle Schwartzman, Brittany Lane, and Jonathan I. Silverberg

Link

Differences between pediatric and adult atopic dermatitis, Hassiel A. Ramírez-Marín and Jonathan I. Silverberg

Link

Food allergy testing in atopic dermatitis, Hassiel A. Ramírez-Marín, Anne Marie Singh, Peck Y. Ong, and Jonathan I. Silverberg

Link

Prevalence and associations of fatigue in childhood atopic dermatitis: a cross-sectional study, Stephanie M. Rangel, Theodore Kim, Anjani Sheth, Alli Blumstein, Jin-Shei Lai, David Cella, Amy S. Paller, and Jonathan I. Silverberg

Link

Numerous Angiomatous Lesions in an Infant, Catherine Reilly, Nidhi Shah, and Kaiane Habeshian

Link

Association of autoimmune blistering disease, and specifically, pemphigus vulgaris, with cardiovascular disease and its risk factors: a systematic review and meta-analysis, Alex M. Rokni, Marissa Ayasse, Adnan Ahmed, Lauren Guggina, Robert W. Kantor, and Jonathan I. Silverberg

Link

Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study, Maria C. Schneeweiss, Julien Kirchgesner, Richard Wyss, Yinzhu Jin, Cassandra York, Joseph F. Merola, Arash Mostaghimi, Jonathan I. Silverberg, Sebastian Schneeweiss, and Robert J. Glynn

Link

Venous Thromboembolism in Chronic Inflammatory Skin Diseases-The Need to Consider Bullous Pemphigoid-Reply, Maria C. Schneeweiss, Jonathan I. Silverberg, and Arash Mostaghimi

Link

Incidence of Bacterial and Nonbacterial Conjunctivitis in Patients With Atopic Dermatitis Treated With Dupilumab: A US Multidatabase Cohort Study, Maria C. Schneeweiss, Richard Wyss, Kristyn Chin, Joseph F. Merola, Jonathan I. Silverberg, Arash Mostaghimi, and Sebastian Schneeweiss

Link

Dermatologic Consequences of Substandard, Spurious, Falsely Labeled, Falsified, and Counterfeit Medications, Gabrielle H. Schwartzman, Paige K. Dekker, Anna S. Silverstein, Natalia M. Fontecilla, and Scott A. Norton

Link

Dermatologic Consequences of Substandard, Spurious, Falsely Labeled, Falsified, and Counterfeit Medications, Gabrielle H. Schwartzman, Paige K. Dekker, Anna S. Silverstein, Natalia M. Fontecilla, and Scott A. Norton

Link

Association of Adult Atopic Dermatitis Severity With Decreased Physical Activity: A Cross-sectional Study, Gabrielle Schwartzman, Donald Lei, Adnan Ahmed, Rajeev Chavda, Sylvie Gabriel, and Jonathan I. Silverberg

Link

Longitudinal course and phenotypes of health-related quality of life in adults with atopic dermatitis, G Schwartzman, D Lei, A Ahmed, R Chavda, S Gabriel, and J I. Silverberg

Link

Patient perspectives of atopic dermatitis: comparative analysis of terminology in social media and scientific literature, identified by a systematic literature review, J I. Silverberg, S R. Feldman, W Smith Begolka, M B. Johnson, C Stanojev, M DiBonaventura, R Rojo Cella, H Valdez, C Feeney, and J P. Thyssen

Link

Pharmacology of orismilast, a potent and selective PDE4 inhibitor, J I. Silverberg, L E. French, R B. Warren, B Strober, K Kjøller, M O. Sommer, P Andres, J Felding, A Weiss, D Tutkunkardas, Tine Skak-Nielsen, and E Guttman

Link

Long-Term Efficacy (up to 68 Weeks) of Baricitinib in Combination with Topical Corticosteroids in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Analysis of Treatment Responders, Partial Responders and Nonresponders Originating from Study BREEZE-AD7, J I. Silverberg, E L. Simpson, J P. Thyssen, T Werfel, T Cardillo, S Colvin, E Pierce, Y Chen, S Chen, and L Eichenfield

Link

Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis, Jonathan I. Silverberg, David N. Adam, Matthew Zirwas, Sunil Kalia, Jan Gutermuth, Andreas Pinter, Andrew E. Pink, Andrea Chiricozzi, Sebastien Barbarot, Thomas Mark, Ann-Marie Tindberg, and Stephan Weidinger

Link

Epidemiology and Burden of Sleep Disturbances in Atopic Dermatitis in US Adults, Jonathan Ian Silverberg, Zelma Chiesa-Fuxench, David Margolis, Mark Boguniewicz, Luz Fonacier, Mitchell Grayson, Eric Simpson, and Peck Ong

Link

Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical Trials, Jonathan I. Silverberg, Mark Boguniewicz, Jon Hanifin, Kim A. Papp, Haixin Zhang, Ana B. Rossi, and Noah A. Levit

Link

Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical Trials, Jonathan I. Silverberg, Mark Boguniewicz, Jon Hanifin, Kim A. Papp, Haixin Zhang, Ana B. Rossi, and Noah A. Levit

Link

Clinical Tailoring of Baricitinib 2 mg in Atopic Dermatitis: Baseline Body Surface Area and Rapid Onset of Action Identifies Response at Week 16, Jonathan I. Silverberg, Mark Boguniewicz, Jill Waibel, Jamie Weisman, Lindsay Strowd, Luna Sun, Yuxin Ding, Meghan Feely, Fabio P. Nunes, and Eric L. Simpson

Link

Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study results, Jonathan I. Silverberg, Marjolein de Bruin-Weller, Thomas Bieber, Weily Soong, Kenji Kabashima, Antonio Costanzo, David Rosmarin, Charles Lynde, John Liu, Amy Gamelli, Jiewei Zeng, Barry Ladizinski, Alvina D. Chu, and Kristian Reich

Link

Comparative Efficacy of Targeted Systemic Therapies for Moderate to Severe Atopic Dermatitis without Topical Corticosteroids: Systematic Review and Network Meta-analysis, Jonathan I. Silverberg, H Chih-Ho Hong, Jacob P. Thyssen, Brian M. Calimlim, Avani Joshi, Henrique D. Teixeira, Eric B. Collins, Marjorie M. Crowell, Scott J. Johnson, and April W. Armstrong

Link

Comparative Efficacy of Targeted Systemic Therapies for Moderate to Severe Atopic Dermatitis without Topical Corticosteroids: Systematic Review and Network Meta-analysis, Jonathan I. Silverberg, H Chih-Ho Hong, Jacob P. Thyssen, Brian M. Calimlim, Avani Joshi, Henrique D. Teixeira, Eric B. Collins, Marjorie M. Crowell, Scott J. Johnson, and April W. Armstrong

Link

Allergens in patients with a diagnosis of seborrheic dermatitis, North American Contact Dermatitis Group data, 2001-2016, Jonathan I. Silverberg, Alexander Hou, Erin M. Warshaw, Howard I. Maibach, Donald V. Belsito, Joel G. DeKoven, Kathryn A. Zug, James S. Taylor, Denis Sasseville, Anthony F. Fransway, Vincent A. DeLeo, Melanie D. Pratt, Margo J. Reeder, Amber R. Atwater, Joseph F. Fowler, Matthew J. Zirwas, James G. Marks, Cory A. Dunnick, and Marie-Claude Houle

Link

Lanolin Allergic Reactions: North American Contact Dermatitis Group Experience, 2001 to 2018, Jonathan I. Silverberg, Nisha Patel, Erin M. Warshaw, Joel G. DeKoven, Amber R. Atwater, Donald V. Belsito, Cory A. Dunnick, Marie-Claude Houle, Margo J. Reeder, Howard I. Maibach, Kathryn A. Zug, James S. Taylor, Denis Sasseville, Anthony F. Fransway, Vincent A. DeLeo, Melanie D. Pratt, Joseph F. Fowler, and Matthew J. Zirwas

Link

Lanolin Allergic Reactions: North American Contact Dermatitis Group Experience, 2001 to 2018, Jonathan I. Silverberg, Nisha Patel, Erin M. Warshaw, Joel G. DeKoven, Amber R. Atwater, Donald V. Belsito, Cory A. Dunnick, Marie-Claude Houle, Margo J. Reeder, Howard I. Maibach, Kathryn A. Zug, James S. Taylor, Denis Sasseville, Anthony F. Fransway, Vincent A. DeLeo, Melanie D. Pratt, Joseph F. Fowler, and Matthew J. Zirwas

Link

Patch testing with cobalt in children and adolescents: North American contact dermatitis group experience, 2001-2018, Jonathan I. Silverberg, Nisha Patel, Erin M. Warshaw, Howard I. Maibach, Donald V. Belsito, Joel G. DeKoven, Kathryn A. Zug, James S. Taylor, Denis Sasseville, Vincent A. DeLeo, Melanie D. Pratt, Margo J. Reeder, Amber R. Atwater, Joseph F. Fowler, and Marie-Claude Houle

Link

Single-question parent-reported global atopic dermatitis severity: A valid instrument in children, Jonathan I. Silverberg, Stephanie M. Rangel, Anjani Sheth, Alli Blumstein, and Amy S. Paller

Link

Dupilumab Treatment Reduces Hospitalizations in Adults with Moderate-to-Severe Atopic Dermatitis, Jonathan I. Silverberg, Norma P. Rubini, Mario C. Pires, Ana B. Rossi, Annie Zhang, Zhen Chen, Noah A. Levit, Jingdong Chao, Brad Shumel, and Gaëlle Bégo-Le Bagousse

Link

Determining Severity Strata for Three Atopic Dermatitis Patient-Reported Outcome Questionnaires: Defining Severity Score Ranges for the Worst Pruritus Numerical Rating Scale and the Atopic Dermatitis Symptom and Impact Scales (ADerm-SS and ADerm-IS), Jonathan I. Silverberg, Eric L. Simpson, Brian M. Calimlim, Leighann Litcher-Kelly, Xiaoran Li, Xiaowu Sun, and Yael A. Leshem

Link

Determining Severity Strata for Three Atopic Dermatitis Patient-Reported Outcome Questionnaires: Defining Severity Score Ranges for the Worst Pruritus Numerical Rating Scale and the Atopic Dermatitis Symptom and Impact Scales (ADerm-SS and ADerm-IS), Jonathan I. Silverberg, Eric L. Simpson, Brian M. Calimlim, Leighann Litcher-Kelly, Xiaoran Li, Xiaowu Sun, and Yael A. Leshem

Link

Predictors of chronic COVID-19 symptoms in a community-based cohort of adults, Jonathan I. Silverberg, Israel Zyskind, Hiam Naiditch, Jason Zimmerman, Aaron E. Glatt, Abraham Pinter, Elitza S. Theel, Michael J. Joyner, D Ashley Hill, Miriam R. Lieberman, Elliot Bigajer, Daniel Stok, Elliot Frank, and Avi Z. Rosenberg

Link

Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long-term efficacy and patient-reported outcomes, Eric Simpson, April Armstrong, Mark Boguniewicz, Zelma C. Chiesa Fuxench, Meghan Feely, Evangeline Pierce, Luna Sun, Yun-Fei Chen, Robinette Angle, and Jonathan I. Silverberg

Link

Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long-term efficacy and patient-reported outcomes, Eric Simpson, April Armstrong, Mark Boguniewicz, Zelma C. Chiesa Fuxench, Meghan Feely, Evangeline Pierce, Luna Sun, Yun-Fei Chen, Robinette Angle, and Jonathan I. Silverberg

Link

Safety of Tralokinumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis: Pooled Analysis of Five Randomized, Double-blind, Placebo-controlled Phase 2 and Phase 3 Trials, Eric L. Simpson, Joseph F. Merola, Jonathan I. Silverberg, Kristian Reich, Richard B. Warren, Delphine Staumont-Sallé, Giampiero Girolomoni, Kim Papp, Marjolein de Bruin-Weller, Jacob P. Thyssen, Rebecca Zachariae, Christiana K. Olsen, and Andreas Wollenberg

Link

Patient-oriented measures for phase 3 studies of tralokinumab for treatment of atopic dermatitis (ECZTRA 1, 2 and 3), Eric L. Simpson, Andreas Wollenberg, Weily Soong, Louise Abildgaard Steffensen, Azra Kurbasic, Shannon Schneider, John Zoidis, and Jonathan I. Silverberg

Link

Olfactory dysfunction in children and adults post-COVID-19 infection in Brooklyn, New York, Tamar A. Smith-Norowitz, Jonathan I. Silverberg, Esther M. Norowitz, Jeffrey Loeffler, Margaret R. Hammerschlag, and Stephan Kohlhoff

Link

Acoustic Shockwave Therapy as an Adjunct to Picosecond Laser for Multicolored Tattoo Removal, Pooja Sodha, Jordan V. Wang, and Paul M. Friedman

Link

High threshold efficacy responses in moderate-to-severe atopic dermatitis are associated with additional quality of life benefits: pooled analyses of abrocitinib monotherapy studies in adults and adolescents, S Ständer, N Bhatia, M J. Gooderham, J I. Silverberg, J P. Thyssen, P Biswas, M DiBonaventura, W Romero, and S A. Farooqui

Link

Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial, Sonja Ständer, Shawn G. Kwatra, Jonathan I. Silverberg, Eric L. Simpson, Jacob P. Thyssen, Gil Yosipovitch, Fan Zhang, Michael C. Cameron, Ricardo Rojo Cella, Hernan Valdez, Marco DiBonaventura, and Claire Feeney

Link

Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial, Linda Stein Gold, Kim Papp, David Pariser, Lawrence Green, Neal Bhatia, Howard Sofen, Lorne Albrecht, Melinda Gooderham, Mindy Chen, Maria Paris, Yao Wang, and Kristina Callis Duffin